Experimental Treatment Could Be "Game-Changing" For Inherited ALS

May 7, 2019 0 Comments

The results of a Phase 2 trial using a drug strategy pioneered by our director, Richard Smith M.D., in collaboration with Ionis Pharmaceuticals and the University of California, San Diego has been reported to demonstrate promising results in a Biogen-sponsored treatment trial.

See the attached link: https://www.cnn.com/2019/05/01/health/als-experimental-treatment-study/index.html?utm_term=image&utm_source=twCNN&utm_content=2019-05-01T23%3A01%3A46&utm_medium=social

No comments for this post

Add a comment